Moleculent Raises $20M to Scale Functional Profiling Platform
Stockholm, Sweden | April 30, 2026 Moleculent has announced the successful closing of a $20 million financing round, aimed...
GxP
Advertisement
Specialised Therapeutics NIKTIMVO Approved for cGVHD
Singapore | May 4, 2026 Specialised Therapeutics has announced that NIKTIMVO® (axatilimab) has received regulatory approval from the Therapeutic...
NIPER and Roche Pharma Boost Education and Research in India
NEW DELHI, India, March 17, 2026 The National Institute of Pharmaceutical Education and Research (NIPER) Raebareli has signed a...
Innovent Biologics Joins Hang Seng Index, Marking Biopharma Breakthrough
SuZhou, China – Nov. 24, 2025 — Innovent Biologics (01801.HK), a leading Chinese biopharmaceutical company focused on oncology, cardiovascular/metabolic,...
MSD Animal Health Data Confirms Efficacy of Intranasal Bovine Coronavirus Vaccine
BOXMEER, The Netherlands — October 23, 2025 — MSD Animal Health, a global leader in veterinary biopharmaceutical innovation, announced...
Advertisements
CS Diagnostics Strengthens Financial Structure Through Share Conversion
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
AbbVie Raises 2025 Outlook as Skyrizi and Rinvoq Surge
NORTH CHICAGO, Ill., November 2, 2025 — AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has raised its annual...
Savara Raises $149.5M to Advance Rare Lung Therapeutic Program
LANGHORNE, Pa., November 2, 2025 — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases,...
PharmaDrug Restructures Debt to Strengthen Biopharma Pipeline
Toronto, Ontario – October 31, 2025 — PharmaDrug Inc. (CSE: PHRX; OTC Pink: LMLLF), a specialty pharmaceutical company focused...
Advertisement
